In this issue of the Proceedings, Roost et al. (1) describe the development of humoral immunity in mice infected with vesicular stomatitis virus (VSV). The authors sacrificed mice at defined intervals following infection, made hybridomas (monoclonal antibody-secreting cell lines) specific for the viral antigen, a surface glycoprotein, and in several ways quantitated the interaction of these antibodies with the antigen. The parameters measured were the virus neutralization titer, the on-rate constant (i.e., the bimolecular rate constant for binding antigen), and the affinity (the intrinsic equilibrium constant for formation of antibody-antigen complexes, equal to the ratio of on-rate to off-rate constants).
Roost et al.
(1) present two findings of potentially great interest. The first is a striking correlation of on-rate with virus neutralization. Studies of the immune response to pathogens seldom mention onrate and, instead, have taken affinity as the relevant parameter in disease resistance. To be sure, Roost et al. (1) also report a correlation between affinity and neutralization, but the correlation with on-rate is statistically stronger. The direct implication is that binding a target antigen rapidly may be as important as the thermodynamic stability of the resulting antibody-antigen complexes in limiting pathogen growth. The authors did not take the further step of testing their antibodies in passive immunizations, but should the superior efficacy of rapid-binding antibodies be validated, the field of immunotherapy, which has largely taken affinity as a guidepost, will require a redirection of effort.
Second, Roost et al. (1) present findings that challenge a bedrock principle of immunology: that there are progressive increases in affinity of antibodies produced during an immune response, a process often referred to as affinity maturation. In the remainder of this commentary we summarize the canonical view of affinity maturation and then suggest how it and the findings of Roost et al. (1) can be reconciled.
The Canonical View. It has long been known that serum antibodies change with time after an animal is first exposed to an antigen. The antibodies produced initially react weakly and those produced later react more effectively, forming more stable aggregates with the antigens. A chemical basis for these changes emerged from studies of small organic groups (haptens), such as 2,4-dinitrophenyl (DNP), as models for the functional regions on antigens (antigenic determinants, or epitopes). After exposure to a protein having attached DNP groups, antibodies isolated from serum 1-2 weeks later bound s-DNP-lysine with low intrinsic affinities (105-106 M-1), and antibodies isolated after a few months bound this ligand with affinities around 107_108 M-1 (2) . After many months, when serum antibodies had fallen to near background levels, another exposure to the antigen ("booster immunization") resulted in prompt appearance of the antibodies with high affinities, as though the B cells that produced these antibodies were selectively enriched in the initial encounter with the antigen and persisted as "memory" cells (3) (4) (5) .
This basic experiment has since been repeated with many different hapten systems (e.g., refs. 6-9) and extended after the development of hybridoma technology (10) (11) (12) (13) . Hybridomas were derived at various stages after immunization of inbred mice, much as Roost et al. (1) have done. Instead of looking at the average antigenbinding properties of the complex mixture of immunoglobulins isolated from serum, exact physical constants were measured for hapten binding to chemically homogeneous (monoclonal) antibody preparations. These experiments invariably confirmed the earlier results: the intrinsic affinity of antibodies from cells isolated early in the response was low and that from those derived later was high. Moreover, there was a shift over time to antibodies with higher on-rate constants (kinetic maturation) (14) . Sequence analysis of the antibody genes (formed by DNA rearrangements at the heavy-and lightchain loci) of the early antibodies showed that these were identical to gene segments encoded in the organism's germline. Hybridomas derived later in the response often used the same germline genes but had somatically acquired point mutations (15) . Some of these mutations were sporadic, but other changes reappeared systematically at the same residue positions. These were correlated with increased affinity (16) (17) (18) (19) , and their role in improving the chemical complementarity of the antibody-antigen interface was elucidated in crystal structure analyses of antibodyhapten complexes (20) (21) (22) .
In contrast to the progressive changes seen with the anti-hapten responses, Roost et al. (1) found high-affinity antibodies (107-1010 M-1) at the very first time point examined, 6 days after infection, and these values did not increase in response to repeated booster injections over 150 days. This result is similar to findings reported several years ago on the apparent absence of affinity maturation in systematically staged sets of anti-lysozyme hybridomas (23) . Given these results, we must choose between two conclusions: either that affinity maturation did not occur or that it did occur but was not detected. One reason it might not have been detected is that at the earliest time point examined the antibodies already had affinities that were close to what we estimate to be the maximal affinity (the affinity "ceiling") that is likely to be found for antibodies produced in normal immune responses.
An Affinity Ceiling. The affinity of some proteins for their ligands can be extremely high: e.g., 1015 M-1 for the avidin-biotin reaction (24) (33) (34) (35) . By measuring these properties of early IgM antibodies to VSV and lysozyme, it should become clear whether affinity maturation is superfluous in the responses to these antigens or whether it occurs so rapidly that its detection requires special efforts. It will be critical when analyzing these antibodies to establish unambiguously that intrinsic affinity and intrinsic kinetic constants are measured, reflecting univalent reactions with antigen. One hopes, therefore, that the confounding effects of multivalent binding will be unequivocally avoided through the use of univalent antigens with intact antibodies or, when the antigen is necessarily polyvalent, through use of univalent Fab or Fab' fragments of the antibodies. 
